Navigation Links
Functional Regeneration of the Macula with Autologous Stem Cells
Date:7/30/2013

QUERETARO, Mexico, July 30, 2013 /PRNewswire/ -- The company CELLMAK is dedicated to biomedical research in regenerative cellular medicine and tissue engineering with a group of scientists led by Biomedical Researcher Mario Camacho.

Five years ago we began our work on clinical research protocols for the functional Regeneration of the Retina, working with cases of Age-related Macular, Glaucoma and Optic Nerve Atrophy, using autologous stem cells from bone marrow with excellent results.  In other countries, at present they are only in the initial clinical research protocols for these ailments. 

We do not commercialize treatments, but since we do not have support from the government or large companies, patients, who are evaluated by the ophthalmologists we work with as viable candidates for our protocols, pay out of their own pockets for the inputs and medical fees involved. 

We Mexicans are proud to be competing with research groups from all over the world, many of them endowed with multi-million dollar support from their governments or major corporations.  

CELLMAK has distinguished itself as the first company in Latin America successfully to introduce Cellular Facial Rejuvenation to the market, using the patient's own fatty tissue cells, and without surgery! 

We are located in the city of Queretaro, one of the safest and most beautiful cities in Mexico, where people come to see us from all over the world. 

Our protocols depend on COFEPRIS, Mexico's regulatory agency for health matters.  At present the FDA has no role whatsoever in regulating us.  

CELLMAK is a company founded by Biomedical Researcher Mario Camacho and his wife, Karyna Camacho, who have worked indefatigably to create the technology and appropriate standards for the application of autologous stem cells (that is, using the patient's own stem cells) for Mexico and the world.

At CELLMAK we work to improve the quality of people's lives, and are putting Mexico in first place, competing at the global level in the generation of new technology. 

Make an appointment now and find out how you can participate in our clinical research protocols.

Mario Camacho is a Biomedical Researcher engaged in comprehensive handling of autologous stem cells, and he works with medical specialists who clinically evaluate viable candidates and deal directly with the patients.

Contact information:

https://www.facebook.com/Cellmak 
e-mail: celulasmadre1@aol.com 
Phone: (52) 442 2200546 and 442 2452997
also soon at: www.cellmak.com


'/>"/>
SOURCE CELLMAK
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Veeva CRM Adds New Survey Functionality to Deepen Customer Understanding and Drive More Relevant Interactions
2. Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment
3. Preliminary Research, Led By Dr. Vincent Giampapa, Finds Aged Adult Stem Cells Can Be Functionally Reprogrammed To Act Like Younger Cells
4. Researchers build functional ovarian tissue in lab
5. New injectable hydrogel encourages regeneration and improves functionality after a heart attack
6. ALCAT Pioneer, Roger Deutsch, to Address "Food Allergies and Intolerances" at the Institute of Functional Medicine Conference in Tampa, February 8-10
7. Neuralstem Cells Induce Significant Functional Improvement In Permanent Rat Spinal Cord Injury, Cell Study Reports
8. New structural information on functionalization of gold nanoparticles
9. Baylor College of Medicine and Gradalis Enter Collaboration Agreement to Utilize Gradalis Bifunctional shRNA Platform in Translational Medicine Research
10. RURO Adds Critical Level Monitoring Functionality to its Inventory Management Software FreezerPro.
11. Seahorse Launches Reagent to Make Functional Fatty Acid Oxidation (FAO) Assays Easy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... Feb. 4, 2016  Spherix Incorporated (Nasdaq: SPEX ... and monetization of intellectual property, today provided an update ... the Northern District of Texas ... Inter Partes Re-examination ("IPR") proceedings that ... The IPR was initiated on only certain claims of ...
(Date:2/3/2016)... , Feb. 3, 2016   ViaCyte, ... with the first pluripotent stem cell-derived islet replacement ... in clinical-stage development, today announced that ViaCyte and ... Companies of Johnson & Johnson, have agreed to ... into ViaCyte.  The agreement provides ViaCyte with an ...
(Date:2/3/2016)... Feb. 3, 2016 New Jersey Health Foundation ... $1 million for researchers in New ... research that demonstrates exciting potential.   ... for the New Jersey Health Foundation Research Grant ... these educational institutions— Princeton University, Rutgers University, Rowan ...
(Date:2/3/2016)... , Feb. 3, 2016  Silk Therapeutics, Inc., today ... round. Silk Therapeutics has now raised a total of $10.25 ... by the company. The Series A2 round was led by ... , with participation from new investors Lear Corporation and ... and Roy P. Disney ; Richard Sackler , MD, ...
Breaking Biology Technology:
(Date:2/2/2016)... 2016 Checkpoint Inhibitors for Cancer – ... Are you interested in the future of cancer ... inhibitors. Visiongain,s report gives those predictions to 2026 ... level. Avoid falling behind in data or ... revenues those emerging cancer therapies can achieve. There ...
(Date:2/2/2016)... Va. , Feb. 2, 2016   ... award from the U.S. Army Research Office and ... the range and sensitivity of the company,s ... Past Accounting Mission and, more generally, defense-related DNA ... DNA phenotyping capabilities (predicting appearance and ancestry from ...
(Date:2/1/2016)... Rising sales of consumer electronics ... intuitive gesture control market size ... consumer electronics coupled with new technological advancements to drive ... through 2020   --> ... advancements to drive global touchfree intuitive gesture control market ...
Breaking Biology News(10 mins):